Kevin Norrett

This profile gathers the share dealings of Kevin Norrett across 2 companies, led by Codexis, Inc. and Soleno Therapeutics Inc. Over a trading history stretching from 8 February 2023 to 21 January 2026, the count stands at 9 filings.

Both buying and selling appear: 1 purchase worth €14k, against 2 sales worth €73k. Taken together, the sales exceed the purchases by €58k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 6 share grants.

The latest filing, published on 23 January 2026, reports a share grant in Soleno Therapeutics Inc. The latest purchase dates back some time: it was published 1,140 days ago, on 12 September 2023. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.